Sort   by:  
 Page size 
UnknownT-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab.
Not available
S-EPMC6075965 | biostudies-literature
UnknownGenome-Wide Methylation Profiling of Peripheral T-Cell Lymphomas Identifies TRIP13 as a Critical Driver of Tumor Proliferation and Survival.
Not available
S-EPMC11348144 | biostudies-literature
UnknownGenome-wide methylation profiling of Peripheral T-cell lymphomas identifies TRIP13 as a critical driver of tumor proliferation and survival.
Not available
S-EPMC10925438 | biostudies-literature
UnknownStrategic foliar nutrition with Sorbitol, Mannitol, and Boron improves physiological performance and yield in Faba beans on reclaimed sandy soil.
Not available
S-EPMC12834954 | biostudies-literature
UnknownPrognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study.
Not available
S-EPMC8767970 | biostudies-literature
UnknownRandomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Not available
S-EPMC8792803 | biostudies-literature
UnknownMetagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections.
Not available
S-EPMC9275031 | biostudies-literature
UnknownThe Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death.
Not available
S-EPMC12308656 | biostudies-literature
UnknownHeart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.
Not available
S-EPMC11683873 | biostudies-literature
UnknownClinical value of circulating bioactive adrenomedullin for prediction of outcome and hydrocortisone response in sepsis patients-a post-hoc analysis of the HYPRESS trial.
Not available
S-EPMC12675558 | biostudies-literature
Sort   by:  
 Page size